Summary:
• An independent public research institute since 1957 performing research in organic and medicinal chemistry, pharmacology, bioanalytics and biophysics;
• One of the leading research institutions in Latvia, 236 FTE employees, including 189 PhD and MSc;
• Over 60 years experience in the drug design and technology development;
• An inventor and co-inventor of 18 original approved drugs and more than 100 new technologies for the production of patent-free medicinal products;
• Located in Riga and possesses about 5000m2 of equipped laboratory space.

Strengths:
• Teams of experienced organic chemists capable to solve challenging synthetic tasks;
• Strong analytical chemistry support and experience in application of advanced structure assignment methods (multidimensional NMR, X-ray analysis etc.);
• Wide range of established in vivo, ex vivo and in vitro pharmacology assays;
• Efficient teamwork with pharmacologists, molecular modeling professionals and other experts for higher success rate.

Main markets

  1. Germany
  2. Sweden
  3. Switzerland
  4. United Kingdom
  5. United States

Target Markets

  1. Germany
  2. Sweden
  3. Switzerland
  4. United Kingdom
  5. United States

Showing similar companies

By the industry in which it operates

Foundation year: 1957

Turnover in the last 5 years

Data are not able

Data are not able

Empty chart placeholder

Export volume over the last 5 years

Data are not able

Data are not able

Empty chart placeholder

Main markets

  1. 1. Germany
  2. 2. Sweden
  3. 3. Switzerland
  4. 4. United Kingdom
  5. 5. United States

Target Markets

  1. 1. Germany
  2. 2. Sweden
  3. 3. Switzerland
  4. 4. United Kingdom
  5. 5. United States

Investing in R&D

Data are not able

Data are not able

Empty chart placeholder

LATVIJAS ORGANISKĀS SINTĒZES INSTITŪTS ATVASINĀTA PUBLISKA PERSONA

Description about enterprise:

Summary:
• An independent public research institute since 1957 performing research in organic and medicinal chemistry, pharmacology, bioanalytics and biophysics;
• One of the leading research institutions in Latvia, 236 FTE employees, including 189 PhD and MSc;
• Over 60 years experience in the drug design and technology development;
• An inventor and co-inventor of 18 original approved drugs and more than 100 new technologies for the production of patent-free medicinal products;
• Located in Riga and possesses about 5000m2 of equipped laboratory space.

Strengths:
• Teams of experienced organic chemists capable to solve challenging synthetic tasks;
• Strong analytical chemistry support and experience in application of advanced structure assignment methods (multidimensional NMR, X-ray analysis etc.);
• Wide range of established in vivo, ex vivo and in vitro pharmacology assays;
• Efficient teamwork with pharmacologists, molecular modeling professionals and other experts for higher success rate.